The impact of SM3 is largely symbolic, serving to acknowledge the significant role that Cowboys for Cancer Research has played in supporting cancer research projects in New Mexico. The memorial highlights the financial contributions made by the organization which have remained within the state, aiming to bolster local cancer research capabilities. This recognition strengthens the connection between community fundraising efforts and state-level appreciation for those who contribute to the fight against cancer.
Summary
Senate Memorial 3 (SM3) recognizes the contributions of Cowboys for Cancer Research to cancer research efforts in New Mexico. Established in 1982, Cowboys for Cancer Research is noted as the largest cancer research fundraiser in the state. The memorial honors the organization for its longstanding efforts in raising funds specifically for cancer research initiatives and declares March 10, 2023, as 'Cowboys for Cancer Research Day' in the Senate. The dedication reflects both historical work and ongoing commitments to finding cures for cancer through local funding.
Sentiment
General sentiment regarding SM3 appears to be positive, with strong support from lawmakers who appreciate the efforts of Cowboys for Cancer Research. The memorial aims to shed light on the collaborative work between different institutions in New Mexico, indicating a united front toward combating cancer. Senators are likely motivated by a shared vision of community engagement and the importance of supporting local cancer initiatives.
Contention
While there may not be significant contention surrounding SM3, discussions may arise related to the broader implications of cancer research funding and potential comparisons with other initiatives. Supporters advocate for continued resources and donations to enhance local cancer research, while perspectives on the effectiveness of fundraising methods and the transparency of fund allocation could surface as points of dialogue.
Relates to ovarian cancer research; requires biennial reporting on recommendations from the health research and science board on the types of data that would be useful for ovarian cancer researchers.